ストックスクリーナーアプリを入手
1.39
6.49%
0.08
前日終値:
$1.31
開ける：
$1.32
24時間の取引高:
426.13K
Relative Volume:
0.18
時価総額：
$57.75M
収益：
$68.68M
当期純損益:
$-60.84M
株価収益率:
-0.8688
EPS:
-1.6
ネットキャッシュフロー:
$-38.42M
1週間 パフォーマンス:
-6.38%
1か月 パフォーマンス:
-13.35%
6か月 パフォーマンス:
-55.57%
1年 パフォーマンス:
-78.27%
1日の値動き範囲:
$1.32
$1.41
1週間の範囲:
$1.31
$1.48
52週間の値動き範囲:
$1.31
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
LUNG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.40 | 54.03M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
128.61 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.37 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
369.78 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.71 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.52 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 開始されました | D. Boral Capital | Buy |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-04 | 開始されました | Lake Street | Buy |
| 2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 開始されました | Craig Hallum | Buy |
| 2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Neutral |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-26 | 開始されました | BofA Securities | Buy |
| 2020-10-26 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 開始されました | Stifel | Buy |
| 2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
Is Pulmonx Corporation stock attractive for hedge fundsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Will Pulmonx Corporation stock sustain high P E ratios2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Pulmonx Corporation (LUNG) stock price, news, quote and history - Yahoo Finance UK
Is Pulmonx Corporation stock trading at a premium valuationAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com
Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen - Defense World
Is Pulmonx Corporation stock entering bullish territoryProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
Can Pulmonx Corporation stock outperform in 2025 bull marketWeekly Trade Recap & Safe Capital Preservation Plans - newser.com
Tick level data insight on Pulmonx Corporation volatility2025 Valuation Update & Precise Buy Zone Identification - newser.com
Historical volatility pattern of Pulmonx Corporation visualizedTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Pulmonx Corporation (NASDAQ:LUNG) Q3 2025 Earnings Call Transcript - Insider Monkey
Pulmonx stock rating reiterated at Buy by Stifel after 3Q results - Investing.com Nigeria
LUNG Stock Rating: D. Boral Capital Maintains Buy Rating with $1 - GuruFocus
How Recent Shifts Are Rewriting the Story for Pulmonx - Yahoo Finance
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... By GuruFocus - Investing.com Canada
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and Strategic Opportunities - GuruFocus
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... - Yahoo Finance
Pulmonx Rides Global Growth On Strong Zephyr Valve Demand - Finimize
Transcript : Pulmonx Corporation, Q3 2025 Earnings Call, Nov 12, 2025 - MarketScreener
Earnings call transcript: Pulmonx beats Q3 2025 earnings expectations By Investing.com - Investing.com Nigeria
Pulmonx earnings beat by $0.08, revenue topped estimates - Investing.com
Earnings call transcript: Pulmonx beats Q3 2025 earnings expectations - Investing.com
PULMONX Earnings Results: $LUNG Reports Quarterly Earnings - Quiver Quantitative
Pulmonx (LUNG) Exceeds Q3 Revenue Expectations, Aiming for Growt - GuruFocus
Pulmonx (LUNG) Adjusts 2025 Financial Projections - GuruFocus
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Lung treatment firm Pulmonx's Q3 revenue up 5%, net loss narrows marginally - MarketScreener
Pulmonx Reports Third Quarter 2025 Financial Results - The Manila Times
Pulmonx's Earnings: A PreviewPulmonx (NASDAQ:LUNG) - Benzinga
Ready to Jump After Recent Trade: Pulmonx Corp (LUNG) - setenews.com
[Form 3] Pulmonx Corp Initial Statement of Beneficial Ownership - Stock Titan
Using data filters to optimize entry into Pulmonx CorporationJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
A better buy-in window may exist right now for Pulmonx Corp (LUNG) - Setenews
Will Pulmonx Corporation stock maintain momentum in 20252025 Sector Review & Safe Entry Point Alerts - newser.com
Visualizing Pulmonx Corporation stock with heatmapsWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - newser.com
What catalysts could drive Pulmonx Corporation stock higherEarnings Performance Report & Low Volatility Stock Recommendations - newser.com
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
Pulmonx Corp (LUNG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Joshi Mehul | Chief Financial Officer & PAO |
Sep 02 '25 |
Sale |
1.60 |
7,936 |
12,698 |
208,489 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Sep 02 '25 |
Sale |
1.60 |
6,543 |
10,469 |
379,788 |
| Lehman David Aaron | GENERAL COUNSEL |
Sep 02 '25 |
Sale |
1.60 |
9,769 |
15,630 |
263,270 |
| Ferrari Richard | Director |
Jun 12 '25 |
Sale |
3.16 |
8,000 |
25,280 |
87,024 |
6.45%
大文字化:
|
ボリューム (24 時間):